Hepatectomy

Oncology·MeSH: Agnosia

1 drug in development·1 company·0 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Hepatectomy — Drugs in Development & Clinical Trials | BioSniper